Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention
Clinical trial NCT01952574 · COMPLETED
Trial details
- NCT number
- NCT01952574
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-06
- Primary completion
- 2014-09-25
- Enrollment
- 483
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.